Quantcast

Latest Artificial pancreas Stories

2011-09-22 11:22:02

Evaluation of the incremental cost to the National Health Service of prescribing analogue insulin The NHS has stumped up an extra £625 million over the past decade on synthetic forms of insulin, when the recommended human alternatives– which are considerably cheaper– would have probably been just as effective, reveals research published online in BMJ Open. The finding comes as a UN health summit in New York this week debates how to step up international efforts to...

2011-09-16 07:00:00

The product is a "smart cap" which, when added to a typical insulin pen, uses a timer to remind diabetics about when they're due for an insulin injection as reported by diabeticlive.com. Tampa, FL (PRWEB) September 16, 2011 âœSmart Capâ for Insulin Pens Reminds Diabetics When itâs Time for an Injection: Diabetics will soon have a new way to remind themselves to take insulin shots. A new product called Timesulin was recently announced at the...

2011-09-17 07:00:00

The Juvenile Diabetes Research Foundation (JDRF) announced on September 14 that it is holding a $100,000 Challenge for the development of a new glucose-sensitive insulin medication that will be used in the treatment of patients with diabetes as reported by diabeticlive.com. Tampa, FL (PRWEB) September 17, 2011 JDRF Offers $100,000 for Glucose-Responsive Insulin Medication: The Juvenile Diabetes Research Foundation (JDRF) announced on September 14 that it is holding a $100,000 Challenge for...

2011-09-12 14:17:33

Say Hebrew University researchers Researchers at the Hebrew University of Jerusalem have identified the key signal that prompts production of insulin-producing beta cells in the pancreas -- a breakthrough discovery that may ultimately help researchers find ways to restore or increase beta cell function in people with type 1 diabetes. The work on the multi-year project was led by Prof. Yuval Dor of the Institute for Medical Research Israel-Canada of the Hebrew University, researchers...

2011-08-01 14:33:51

Research published in The Cochrane Library found that the risk of death and cardiovascular disease, such as stroke, was unchanged whether glucose control was intense or conventional. They did find, however, that when aiming to keep blood glucose levels at the lower intensive level, the chance of damaging small blood vessels in the body, potentially leading to damage in the eyes and kidneys, is reduced. But aiming for this lower level with the more intensive glucose control substantially...

2011-07-20 12:47:00

JDRF says Pending Artificial Pancreas Guidance is FDA's Opportunity to Turn the Tide NEW YORK, July 20, 2011 /PRNewswire-USNewswire/ -- The Juvenile Diabetes Research Foundation (JDRF) welcomed Congress's attention today to the important issue of medical device regulatory reform and reiterated the life-changing difference the FDA's pending artificial pancreas guidance will make in the lives of millions of individuals with type 1 diabetes across the country. The hearing, "FDA Medical...

2011-06-28 07:30:57

(Ivanhoe Newswire) --  The 25.8 million Americans who have diabetes may soon be free of finger pricks and daily insulin dosing. Mayo Clinic endocrinologists are developing an artificial pancreas that will deliver insulin automatically and with an individualized precision never before possible. "The effects of low-intensity physical activity, mimicking activities of daily living, measured with precise accelerometers on glucose variability in type 1 diabetes had not been examined," ...

2011-06-27 12:17:32

The 25.8 million Americans who have diabetes may soon be free of finger pricks and daily insulin dosing. Mayo Clinic endocrinologists Yogish Kudva, M.B.B.S., and Ananda Basu, M.B.B.S., M.D., are developing an artificial pancreas that will deliver insulin automatically and with an individualized precision never before possible. As part of this effort, Drs. Kudva and Basu will present their latest findings on how the mundane movements of everyday life affect blood sugar to the American Diabetes...

2011-06-22 14:57:00

Concerns about progress, patient access voiced at Senate hearing for JDRF's Children's Congress WASHINGTON, June 22, 2011 /PRNewswire-USNewswire/ -- Kevin Kline and four children with type 1 diabetes urged the Food and Drug Administration (FDA) to take immediate action to accelerate the research and review of artificial pancreas systems at a hearing before the Senate Committee on Homeland Security and Government Affairs. The hearing, "Transforming Lives through Diabetes Research," was...


Word of the Day
pungle
  • To take pains; labor assiduously with little progress.
This word comes from the Spanish 'pongale,' put it.
Related